Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales (2016 - 2025)

Ironwood Pharmaceuticals' Return on Sales history spans 16 years, with the latest figure at 1.75% for Q4 2025.

  • For Q4 2025, Return on Sales fell 177.0% year-over-year to 1.75%; the TTM value through Dec 2025 reached 0.19%, down 19.0%, while the annual FY2025 figure was 0.39%, 39.0% up from the prior year.
  • Return on Sales for Q4 2025 was 1.75% at Ironwood Pharmaceuticals, down from 0.33% in the prior quarter.
  • Across five years, Return on Sales topped out at 3.76% in Q2 2021 and bottomed at 10.15% in Q2 2023.
  • The 5-year median for Return on Sales is 0.3% (2025), against an average of 0.31%.
  • The largest annual shift saw Return on Sales tumbled -1053bps in 2023 before it surged 1014bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.35% in 2021, then surged by 203bps to 1.07% in 2022, then tumbled by -282bps to 1.94% in 2023, then surged by 101bps to 0.02% in 2024, then tumbled by -7118bps to 1.75% in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Return on Sales are 1.75% (Q4 2025), 0.33% (Q3 2025), and 0.28% (Q2 2025).